OM
EGRX
Opaleye Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-130,000
| Closed | -$7.75M | – | 42 |
|
|
2017
Q3 | $7.75M | Buy |
130,000
+70,000
| +117% | +$4.17M | 2.74% | 13 |
|
|
2017
Q2 | $4.73M | Buy |
60,000
+10,000
| +20% | +$789K | 1.98% | 18 |
|
|
2017
Q1 | $4.15M | Hold |
50,000
| – | – | 2.06% | 18 |
|
|
2016
Q4 | $3.97M | Sell |
50,000
-20,000
| -29% | -$1.59M | 2.34% | 17 |
|
|
2016
Q3 | $4.9M | Buy |
70,000
+20,000
| +40% | +$1.4M | 2.56% | 12 |
|
|
2016
Q2 | $1.94M | Sell |
50,000
-10,000
| -17% | -$388K | 1.3% | 31 |
|
|
2016
Q1 | $2.43M | Sell |
60,000
-25,000
| -29% | -$1.01M | 1.52% | 28 |
|
|
2015
Q4 | $7.54M | Buy |
85,000
+11,800
| +16% | +$1.05M | 3.15% | 10 |
|
|
2015
Q3 | $5.42M | Buy |
73,200
+23,200
| +46% | +$1.72M | 2.67% | 16 |
|
|
2015
Q2 | $4.04M | Buy |
+50,000
| New | +$4.04M | 1.61% | 25 |
|